Effects of Tribulus Terrestris in Women With Hypoactive Sexual Desire Disorder

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

44 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-05-31

Study Completion Date

2015-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hypoactive Sexual Desire Disorder (HSDD) is the most prevalent female sexual dysfunction in society and is strongly linked to the quality of life of women. The androgen hormones decline over age in the premenopausal period, which occurs around 20 years. Tribulus terrestris is a plant native to India, recommended in the treatment of infertility, low libido and impotence. Its main active ingredient is the protodioscin, which has been attributed to an increase in testosterone levels and improved sexual function. The aim of this study is to evaluate the effects of Tribulus Terrestris in premenopausal women with HSDD.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of Tribulus Terrestris in Postmenopausal Women With Hypoactive Sexual Desire Disorder

NCT01975649

Menopause Sexual Abstinence

COMPLETED PHASE4

Dehydroepiandrosterone (DHEA) Treatment in Women and Men Experiencing Hypoactive Sexual Desire Disorder

NCT00916396

Hypoactive Sexual Desire Disorder

UNKNOWN NA

Testosterone in Female Hypoactive Sexual Desire Disorder

NCT00140153

Hypoactive Sexual Desire Disorder

COMPLETED PHASE3

Low Sexual Desire and Metabolic Syndrome

NCT02430987

Menopause Metabolic Syndrome Hypoactive Sexual Desire Disorder +2 more

COMPLETED NA

Stress Hormones, Mood and Women's Sexual Desire (MODEST)

NCT01702818

Hypoactive Sexual Desire Disorder (HSDD)

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypoactive Sexual Desire Disfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo

patients will use placebo for 120 days

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

patients will take one pill a day (the same shape of the drug)

Tribulus Terrestris

patients will use Tribulus terrestris (750 mg/day) during 120 days

Group Type EXPERIMENTAL

tribulus terrestris

Intervention Type DRUG

patients will use 750mg/day of tribulus terrestris

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

tribulus terrestris

patients will use 750mg/day of tribulus terrestris

Intervention Type DRUG

Placebo

patients will take one pill a day (the same shape of the drug)

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

tribulus

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* regular menstrual cycle
* with no use of hormonal contraception within the last 3 months
* without any medication, drugs or alcohol.
* Healthy patients without systemic or psychiatric disease

Exclusion Criteria

* Patients with amenorrhea and/or pregnant.

* Patients who underwent bilateral oophorectomy.
* Patient smoker (10 cigarettes per day).
* Patients with blood pressure \> 160/90 mm Hg.
* Patient with breast or endometrial carcinoma.
* Patients with a history of myocardial infarction.
* Patient with Diabetes.
* Patient with vaginal bleeding from any source.
* Patients with hepatic injury.
* Patients with active thrombophlebitis or thromboembolic disorders recent
* Patients with interpersonal relationship problems with your relationship or partner
* Patients with sexual problems from your partner

Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No